JPMorgan Chase Reduces Stake in Exponent, Inc.

Hedge fund sells 157,457 shares of the business services provider

Mar. 23, 2026 at 8:52am

Got story updates? Submit your updates here. ›

JPMorgan Chase & Co. reduced its holdings in Exponent, Inc. (NASDAQ:EXPO) by 24.7% during the third quarter, according to the company's 13F filing with the SEC. The fund now owns 480,624 shares of the business services provider's stock, valued at $33,394,000.

Why it matters

Exponent is a prominent engineering and scientific consulting firm that provides analysis and advisory services to clients across various industries. JPMorgan Chase's reduction in its stake in the company could signal a shift in investor sentiment or portfolio adjustments by the hedge fund.

The details

According to the 13F filing, JPMorgan Chase sold 157,457 shares of Exponent during the third quarter. The fund now owns approximately 0.96% of the company's outstanding shares. Other hedge funds have also made changes to their Exponent holdings, with some increasing their positions and others, like Voloridge Investment Management, also reducing their stakes.

  • JPMorgan Chase reduced its Exponent holdings during the third quarter of 2026.

The players

JPMorgan Chase & Co.

A multinational investment bank and financial services company that is one of the largest hedge fund investors in Exponent, Inc.

Exponent, Inc.

An engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across various industries.

Got photos? Submit your photos here. ›

The takeaway

JPMorgan Chase's reduction in its Exponent holdings could signal a broader shift in investor sentiment towards the consulting firm, though the reasons behind the hedge fund's portfolio adjustments are not entirely clear from the available information.